Quantum Leap Healthcare Collaborative Announce Termination of the Cyproheptadine Treatment Arm for Critically Ill COVID-19 Patients in the I-Spy COVID Trial

0
35
Quantum Leap Healthcare Collaborative, sponsor of the I-SPY COVID Trial, announced that the cyproheptadine arm of the study has been terminated.
[PR Newswire]
Press Release